NUS NYSE
Nu Skin Enterprises, Inc.
1W: -4.8%
1M: +2.2%
3M: -10.4%
YTD: -50.7%
1Y: -56.8%
3Y: -74.5%
5Y: -86.7%
$4.73
+0.04 (+0.85%)
Pre-Market: $4.80 (+0.07, +1.48%)
Weekly Expected Move ±4.7%
$4
$5
$5
$5
$5
Credit Risk of going bust: higher than 71% of companies Debt: 53.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.35 (down 93%), Nu Skin Enterprises, Inc. would be worth roughly what it owes.
Total debt $263.7M against a stock market value of $230.2M.
Distance to default 3.34 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $116.8M (short-term plus half of long-term), stock volatility 47.5%; Altman Z 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.35 (down 93%), Nu Skin Enterprises, Inc. would be worth roughly what it owes.
Total debt $263.7M against a stock market value of $230.2M.
Distance to default 3.34 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $116.8M (short-term plus half of long-term), stock volatility 47.5%; Altman Z 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2025-01-03
Earliest Filing
2025-01-03
Latest Filing
target: 2
acquirer: 1
partner: 1
Counterparties (Filed by NUS)
4 relationshipsCompanies named in NUS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Clout.io Holdings, Inc. | — | acquirer | Purchased all equity in Mavely from Mavely Seller LLC for $230 million cash and $20 million in stock. | 2025-01-03 | View |
| Mavrck LLC | — | partner | Direct wholly-owned subsidiary of Clout.io Holdings, Inc. and party to the Unit Purchase Agreement. | 2025-01-03 | View |
| Mavely LLC | — | target | The target company whose equity was purchased by Clout.io Holdings, Inc. and Mavrck LLC. | 2025-01-03 | View |
| Mavely Seller LLC | — | target | Delaware LLC and subsidiary of Nu Skin Enterprises, Inc. that sold its equity in Mavely LLC. | 2025-01-03 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-21 | Officer/Director Change | View | |
| 2026-08-10 | Earnings Release; Exhibits | View | |
| 2026-05-29 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-08 | Officer/Director Change | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-27 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-03-20 | Officer/Director Change; Exhibits | View | |
| 2026-03-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-02-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-30 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-06 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-03 | Entry into Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Regula | Agreement Acquisition | View |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-01 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2024-09-12 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR